These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23427045)

  • 21. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
    Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
    J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-molecule FRET unveils induced-fit mechanism for substrate selectivity in flap endonuclease 1.
    Rashid F; Harris PD; Zaher MS; Sobhy MA; Joudeh LI; Yan C; Piwonski H; Tsutakawa SE; Ivanov I; Tainer JA; Habuchi S; Hamdan SM
    Elife; 2017 Feb; 6():. PubMed ID: 28230529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bioluminogenic HDAC activity assay: validation and screening.
    Halley F; Reinshagen J; Ellinger B; Wolf M; Niles AL; Evans NJ; Kirkland TA; Wagner JM; Jung M; Gribbon P; Gul S
    J Biomol Screen; 2011 Dec; 16(10):1227-35. PubMed ID: 21832257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A fluorescence-based assay for the apurinic/apyrimidinic-site cleavage activity of human tyrosyl-DNA phosphodiesterase 1.
    Thomson GJ; Hamilton NS; Hopkins GV; Waddell ID; Watson AJ; Ogilvie DJ
    Anal Biochem; 2013 Sep; 440(1):1-5. PubMed ID: 23688965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development.
    van Pel DM; Barrett IJ; Shimizu Y; Sajesh BV; Guppy BJ; Pfeifer T; McManus KJ; Hieter P
    PLoS Genet; 2013; 9(1):e1003254. PubMed ID: 23382697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors.
    Tumey LN; Bom D; Huck B; Gleason E; Wang J; Silver D; Brunden K; Boozer S; Rundlett S; Sherf B; Murphy S; Dent T; Leventhal C; Bailey A; Harrington J; Bennani YL
    Bioorg Med Chem Lett; 2005 Jan; 15(2):277-81. PubMed ID: 15603939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation.
    Wang Z; Bhattacharya A; Ivanov DN
    PLoS One; 2015; 10(9):e0138780. PubMed ID: 26390015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential and multistep substrate interrogation provides the scaffold for specificity in human flap endonuclease 1.
    Sobhy MA; Joudeh LI; Huang X; Takahashi M; Hamdan SM
    Cell Rep; 2013 Jun; 3(6):1785-94. PubMed ID: 23746444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput fluorescence polarization method for identifying ligands of LOX-1.
    Zhang TT; Huang ZT; Dai Y; Chen XP; Zhu P; Du GH
    Acta Pharmacol Sin; 2006 Apr; 27(4):447-52. PubMed ID: 16539845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
    Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
    Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a fluorescent intensity assay amenable for high-throughput screening for determining 15-lipoxygenase activity.
    Dahlström M; Forsström D; Johannesson M; Huque-Andersson Y; Björk M; Silfverplatz E; Sanin A; Schaal W; Pelcman B; Forsell PK
    J Biomol Screen; 2010 Jul; 15(6):671-9. PubMed ID: 20581078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases.
    Gaudet EA; Huang KS; Zhang Y; Huang W; Mark D; Sportsman JR
    J Biomol Screen; 2003 Apr; 8(2):164-75. PubMed ID: 12844437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and activity assay of recombinant flap endonuclease 1].
    Sheng N; Ma Y; Wang J; Zou B; Zhou G
    Sheng Wu Gong Cheng Xue Bao; 2016 Oct; 32(10):1433-1442. PubMed ID: 29027452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site.
    Exell JC; Thompson MJ; Finger LD; Shaw SJ; Debreczeni J; Ward TA; McWhirter C; Siöberg CL; Martinez Molina D; Abbott WM; Jones CD; Nissink JW; Durant ST; Grasby JA
    Nat Chem Biol; 2016 Oct; 12(10):815-21. PubMed ID: 27526030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of flap modifications on human FEN1 cleavage.
    Bornarth CJ; Ranalli TA; Henricksen LA; Wahl AF; Bambara RA
    Biochemistry; 1999 Oct; 38(40):13347-54. PubMed ID: 10529210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fluorescence polarization assay for screening inhibitors against the ribonuclease H activity of HIV-1 reverse transcriptase.
    Nakayama GR; Bingham P; Tan D; Maegley KA
    Anal Biochem; 2006 Apr; 351(2):260-5. PubMed ID: 16527235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-Resolved Fluorescence Resonance Energy Transfer Assay for Discovery of Small-Molecule Inhibitors of Methyl-CpG Binding Domain Protein 2.
    Wyhs N; Walker D; Giovinazzo H; Yegnasubramanian S; Nelson WG
    J Biomol Screen; 2014 Aug; 19(7):1060-9. PubMed ID: 24608100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-throughput screen for receptor protein tyrosine phosphatase-gamma selective inhibitors.
    Appiah KK; Kostich WA; Gerritz SW; Huang Y; Hamman BD; Allen J; Zhang W; Lanthorn TH; Albright CF; Westphal R; Banks MN; O'Connell JC
    J Biomol Screen; 2011 Jun; 16(5):476-85. PubMed ID: 21406618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of high-throughput screening.
    Entzeroth M; Flotow H; Condron P
    Curr Protoc Pharmacol; 2009 Mar; Chapter 9():Unit 9.4. PubMed ID: 22294406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.